ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZN AstraZeneca PLC

54.17
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Name Symbol Market Type
AstraZeneca PLC NYSE:AZN NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 54.17 0 01:00:00

ADRs End Mostly Up; Shire Trades Actively

16/02/2017 9:58pm

Dow Jones News


AstraZeneca (NYSE:AZN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more AstraZeneca Charts.

International stocks trading in New York closed mostly higher on Thursday.

The BNY Mellon index of American depositary receipts edged up 0.15% to 133.68. The European index improved 0.27% to 125.04 and the Asian index increased 0.20% to 152.63.

Meanwhile, the Latin American index fell 1.1% to 232.72, and the emerging-markets index eased 0.08% to 272.23.

Shire PLC (SHPG, SHP.LN) was among the companies with ADRs that traded actively.

 

AstraZeneca PLC (AZN, AZN.LN), BP PLC (BP, BP.LN) and Royal Dutch Shell PLC (RDSA, RDSA.LN, RDSB, RDSB.LN) were among the companies with ADRs trading in New York that began trading ex-dividend. The ex-dividend date is the usually-day-long period in which investors cannot buy a stock and still receive its dividend, said Accendo Markets analyst Michael van Dulken. ADRs of AstraZeneca fell 0.28% to $28.76, BP's fell 0.36% to $33.68, and Royal Dutch Shell's fell 0.77% to $52.96.

 

Dublin-based drug maker Shire's fourth-quarter profit surged as its recently acquired Baxalta business added about $1.8 billion in revenue. ADRs rose 2.6% to $178.70.

 

Turkey's biggest mobile phone operator Turkcell's (TKC, TCELL.IS) revenue and earnings before interest, taxes, depreciation and amortization, or Ebitda--a common measure of cash flow--beat analysts' consensus in the most recent period. ADRs rose 2.3% to $7.72.

 

(END) Dow Jones Newswires

February 16, 2017 16:43 ET (21:43 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year AstraZeneca Chart

1 Year AstraZeneca Chart

1 Month AstraZeneca Chart

1 Month AstraZeneca Chart

Your Recent History

Delayed Upgrade Clock